Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Massard

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2009
Combining carboplatin and etoposide in docetaxel-pretreated patients with castration-resistant prostate cancer: a prospective study evaluating also neuroendocrine featuresY Loriot, C Massard, M Gross-Goupil, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|July 4, 2012
Nanoporous surface wetting behavior: the line tension influenceV Raspal, K O Awitor, C Massard, et al.
The British Journal of Dermatology|May 27, 2009
Cutaneous side-effects in patients on long-term treatment with epidermal growth factor receptor inhibitorsA Osio, C Mateus, J-C Soria, et al.
Oncogene|April 19, 2006
hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathwayC Massard, Y Zermati, A-L Pauleau, et al.
Bulletin Du Cancer|January 12, 2011
[Following communications made at American Society of Clinical Oncology 2010, what will change our practice? The point of view of the editorial board of Bulletin du Cancer]T André, M Wislez, A Goncalves, et al.
ESMO Open|September 18, 2025
From toxicity assessment to adaptive safety care: implementing comprehensive fast-track safety evaluation for anticancer drug developmentS Champiat, K Ouali, A Laparra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2013
Triple combination of bevacizumab, gemcitabine and platinum salt in metastatic collecting duct carcinomaN Pécuchet, F Bigot, J Gachet, et al.
Lung Cancer (Amsterdam, Netherlands)|June 3, 2014
Efficacy of phase 1 trials in malignant pleural mesothelioma: description of a series of patients at a single institutionJ Raphael, G Le Teuff, A Hollebecque, et al.
Cancer Chemotherapy and Pharmacology|August 28, 2022
A phase 1b study of crenigacestat (LY3039478) in combination with gemcitabine and cisplatin or gemcitabine and carboplatin in patients with advanced or metastatic solid tumorsC Massard, P A Cassier, A Azaro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2011
Sexual life of male patients with advanced renal cancer treated with angiogenesis inhibitorsT Bessede, C Massard, B Albouy, et al.
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2009
Combining carboplatin and etoposide in docetaxel-pretreated patients with castration-resistant prostate cancer: a prospective study evaluating also neuroendocrine featuresY Loriot, C Massard, M Gross-Goupil, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|July 4, 2012
Nanoporous surface wetting behavior: the line tension influenceV Raspal, K O Awitor, C Massard, et al.
The British Journal of Dermatology|May 27, 2009
Cutaneous side-effects in patients on long-term treatment with epidermal growth factor receptor inhibitorsA Osio, C Mateus, J-C Soria, et al.
Oncogene|April 19, 2006
hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathwayC Massard, Y Zermati, A-L Pauleau, et al.
Bulletin Du Cancer|January 12, 2011
[Following communications made at American Society of Clinical Oncology 2010, what will change our practice? The point of view of the editorial board of Bulletin du Cancer]T André, M Wislez, A Goncalves, et al.
ESMO Open|September 18, 2025
From toxicity assessment to adaptive safety care: implementing comprehensive fast-track safety evaluation for anticancer drug developmentS Champiat, K Ouali, A Laparra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2013
Triple combination of bevacizumab, gemcitabine and platinum salt in metastatic collecting duct carcinomaN Pécuchet, F Bigot, J Gachet, et al.
Lung Cancer (Amsterdam, Netherlands)|June 3, 2014
Efficacy of phase 1 trials in malignant pleural mesothelioma: description of a series of patients at a single institutionJ Raphael, G Le Teuff, A Hollebecque, et al.
Cancer Chemotherapy and Pharmacology|August 28, 2022
A phase 1b study of crenigacestat (LY3039478) in combination with gemcitabine and cisplatin or gemcitabine and carboplatin in patients with advanced or metastatic solid tumorsC Massard, P A Cassier, A Azaro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2011
Sexual life of male patients with advanced renal cancer treated with angiogenesis inhibitorsT Bessede, C Massard, B Albouy, et al.
Pageof 9